Novartis Pharma AG
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$20.0M
Doctors Paid
639
Transactions
4,246
2024 Total
$513,495
Payment Breakdown by Category
Research$8.9M (44.4%)
Consulting$4.9M (24.7%)
Royalty/License$4.5M (22.3%)
Travel$1.6M (8.1%)
Food & Beverage$54,280 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $8.9M | 1,102 | 44.4% |
| Consulting Fee | $4.9M | 1,128 | 24.7% |
| Royalty or License | $4.5M | 21 | 22.3% |
| Travel and Lodging | $1.6M | 1,246 | 8.1% |
| Food and Beverage | $54,280 | 726 | 0.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $50,695 | 1 | 0.3% |
| Education | $13,639 | 20 | 0.1% |
| Honoraria | $5,220 | 2 | 0.0% |
Payments by Type
General
$11.1M
3,144 transactions
Research
$8.9M
1,102 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| CPZP034X2203 | $731,651 | 0 | 16 |
| CLCZ696G2301 | $686,636 | 2 | 44 |
| CLAP016B2301 | $683,482 | 0 | 16 |
| CAIN457A2403 | $617,730 | 0 | 3 |
| COMB157G2011R | $600,000 | 0 | 5 |
| CACZ885M2301 | $591,089 | 2 | 17 |
| COMB157G2304 | $577,163 | 0 | 3 |
| CLCZ696D2301 | $541,011 | 6 | 42 |
| Publication support research related | $343,225 | 72 | 160 |
| COMB157G2304R | $328,036 | 0 | 3 |
| CINC424B2301 | $326,933 | 1 | 78 |
| CAIN457F2304 | $316,437 | 0 | 46 |
| PARADISE-MI | $298,748 | 0 | 9 |
| CRTH258B2301, CRTH258B2302, CRTH258C2301, CRTH258C2302, CRTH258AUS04 | $251,094 | 5 | 13 |
| CLCZ696B2301 | $200,658 | 0 | 3 |
| CLCZ696B2319 | $138,928 | 3 | 34 |
| CLCZ696B2320 | $132,934 | 4 | 42 |
| CRTH258B2301 & CRTH258B2302 | $125,426 | 1 | 7 |
| CAIN457F2304E1 | $104,640 | 0 | 35 |
| CSEG101B2201 | $86,887 | 5 | 39 |
| AIN457F2304E1 | $67,946 | 0 | 10 |
| Rheumatology Pipeline Studies | $58,972 | 3 | 8 |
| CABL001J12301 | $55,044 | 5 | 55 |
| CLCZ696B2319 (PANORAMA-HF) | $49,698 | 0 | 4 |
| Paragon HF Secondary Analysis | $48,420 | 0 | 1 |
| CKJX839B12302 | $44,777 | 3 | 26 |
| CDDO001E2001 | $38,694 | 0 | 5 |
| CRTH258C2301 & CRTH258C2302 | $37,617 | 1 | 3 |
| CCTL019E2202 | $35,750 | 3 | 10 |
| CAMG334A2304 | $33,120 | 2 | 9 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2023 |
|---|---|---|---|---|
| Scott Solomon, Md, MD | Cardiovascular Disease | Boston, MA | $183,812 | $0 |
| Ingrid Scott, Md, MD | Ophthalmology | Hershey, PA | $174,148 | $0 |
| Atulya Deodhar, Md, MD | Rheumatology | Portland, OR | $172,336 | $0 |
| Javed Butler, Md, Mph, MD, MPH | Cardiovascular Disease | Jackson, MS | $163,583 | $0 |
| Dr. Arshad Khanani, M.d, M.D | Ophthalmology | Reno, NV | $162,480 | $0 |
| Philip Mease, Md, MD | Rheumatology | Seattle, WA | $161,934 | $0 |
| Darius Moshfeghi, Md, MD | Ophthalmology | Palo Alto, CA | $144,332 | $0 |
| Robert Shaddy, Md, MD | Pediatrics | Philadelphia, PA | $139,171 | $0 |
| Jerry Wolinsky, M.d, M.D | Neurology | Houston, TX | $126,995 | $0 |
| Peter Kaiser, Md, MD | Ophthalmology | Cleveland, OH | $116,228 | $0 |
| Dr. Justis Ehlers, M.d, M.D | Ophthalmology | Cleveland, OH | $116,092 | $0 |
| Charles Wykoff, Md, Phd, MD, PHD | Retina Specialist | Bellaire, TX | $111,541 | $0 |
| Jeffrey Heier | Ophthalmology | Boston, MA | $106,380 | $0 |
| Donald Levine, Md, MD | Internal Medicine | Detroit, MI | $101,276 | $0 |
| Charles Decarli, Md, MD | Neurology | Sacramento, CA | $98,229 | $0 |
| Gary Felker, M.d, M.D | Cardiovascular Disease | Durham, NC | $97,416 | $0 |
| Dr. Bruce Cree, M.d, M.D | Neurology | San Francisco, CA | $96,645 | $0 |
| Srinivas Sadda, Md, MD | Ophthalmology | Pasadena, CA | $90,284 | $0 |
| Dr. Lianne Gensler, M.d, M.D | Rheumatology | San Francisco, CA | $90,247 | $0 |
| Carl June, Md, MD | Medical Oncology | Philadelphia, PA | $86,864 | $0 |
| Dr. Bruce Zuraw, Md, MD | Allergy & Immunology | San Diego, CA | $86,110 | $0 |
| Amit Bar-Or | Neurology | Philadelphia, PA | $84,535 | $0 |
| Gary Francis, Md, MD | Internal Medicine | Mpls, MN | $80,287 | $0 |
| Dr. James Januzzi, Md, MD | Internal Medicine | Boston, MA | $78,665 | $0 |
| David Brown, M.d, M.D | Ophthalmology | Houston, TX | $77,982 | $0 |
Ad
Top Products
- MID $4.0M
- COSENTYX $1.4M
Associated Products (88)
- MID $4.0M
- ACZ885M $582,246
- PZP034X_VOTRIENT_ONCOLOGY $581,190
- LCZ696D_ENTRESTO_CARDIOVASCULAR $561,531
- AIN457F_COSENTYX_IMMUNOLOGY $479,393
- LCZ696B $478,293
- RTH258C_BEOVU_OPHTHALMOLOGY $391,912
- LCZ696B_ENTRESTO_CARDIOVASCULAR $365,380
- BLZ_BEOVU_OPHTHALMOLOGY $350,373
- AIN457F $327,900
- INC424B $326,933
- LCZ696G_ENTRESTO_CARDIOVASCULAR $300,392
- LCZ696D $245,431
- LAP016B $238,087
- LAP016B_TYKERB_ONCOLOGY $237,624
- OMB157G $225,881
- ACZ885M_ILARIS_IMMUNOLOGY $184,475
- LCZ696G $174,400
- FTY720D $165,369
- IGE025A $154,633
- RTH258A_BEOVU_OPHTHALMOLOGY $128,496
- AIN457A $122,920
- COSENTYX_COSENTYX_DERMATOLOGY $119,214
- Gilenya $109,264
- GLI $100,000
- GLI_GLEEVEC_ONCOLOGY $100,000
- RFB002H $95,888
- CTL019 $94,109
- AMG334A_AIMOVIG_NEUROSCIENCE $92,899
- BAF312A_MAYZENT_NEUROSCIENCE $84,689
- OMB157G_ARZERRA_HEMATOLOGY $81,817
- LCZ696 $76,598
- TRI476B $75,000
- AIN457A_COSENTYX_DERMATOLOGY $71,430
- FTY720D_GILENYA_NEUROSCIENCE $66,122
- QVA149A $60,241
- RTH258A $56,535
- LCZ696_ENTRESTO_CARDIOVASCULAR $52,598
- AFFINITOR $44,919
- AIN457M_COSENTYX_DERMATOLOGY $41,308
- FTY $40,703
- CFZ533X $39,475
- SECUKINUMAB_COSENTYX_DERMATOLOGY $39,073
- BVU_BEOVU_OPHTHALMOLOGY $37,813
- PRM_PROMACTA_ONCOLOGY $33,505
- OMB157B $32,443
- SEG101B_ADAKVEO_HEMATOLOGY $31,182
- Afinitor $29,813
- RTH258B_BEOVU_OPHTHALMOLOGY $27,869
- RYDAPT_RYDAPT_HEMATOLOGY $24,594
- ACZ885D $23,437
- RTH258D_BEOVU_OPHTHALMOLOGY $23,256
- PROMACTA_PROMACTA_ONCOLOGY $22,315
- CANAKINUMAB_ILARIS_IMMUNOLOGY $22,068
- AMG334A $21,636
- RAD001H $21,367
- QVJ499A $21,057
- LAM320B $20,143
- ACZ885G $19,714
- KYM_KYMRIAH_ONCOLOGY $19,286
- AIN_COSENTYX_IMMUNOLOGY $19,121
- IGE025A_XOLAIR _RESPIRATORY $19,049
- SECUKINUMAB $18,637
- SYS $18,215
- AMG334_AIMOVIG_NEUROSCIENCE $18,069
- AIN457H $17,612
- CRH_COSENTYX_IMMUNOLOGY $17,515
- PKC412 $17,476
- MZT_MAYZENT_NEUROSCIENCE $17,138
- LEE011 $16,481
- FTD_GILENYA_NEUROSCIENCE $15,710
- AIN457_COSENTYX_DERMATOLOGY $15,402
- ACZ885N $15,115
- OMB157A $14,902
- CTL019_KYMRIAH_ONCOLOGY $14,847
- LEE011F $14,384
- Votrient $14,235
- JAKAVI $13,850
- FOR258D $13,817
- DRB436X $12,960
- Exjade $12,632
- KISQALI_KISQALI_ONCOLOGY $12,364
- AIN_COSENTYX_DERMATOLOGY $11,850
- LCZ696A $11,276
- INC424B_JAKAFI_ONCOLOGY $11,004
- RFB002A $10,479
- ENTRESTO_ENTRESTO_CARDIOVASCULAR $10,296
- ENA713D $10,105
Payment Categories
- Food & Beverage $54,280
- Consulting $4.9M
- Travel & Lodging $1.6M
- Research $8.9M
- Royalties $4.5M
About Novartis Pharma AG
Novartis Pharma AG has made $20.0M in payments to 639 healthcare providers, recorded across 4,246 transactions in the CMS Open Payments database. In 2024, the company paid $513,495. The top product by payment volume is MID ($4.0M).
Payments were distributed across 71 medical specialties. The top specialty by payment amount is Ophthalmology ($1.8M to 79 doctors).
Payment categories include: Food & Beverage ($54,280), Consulting ($4.9M), Research ($8.9M), Travel & Lodging ($1.6M), Royalties ($4.5M).
Novartis Pharma AG is associated with 88 products in the CMS Open Payments database, including MID, ACZ885M, and PZP034X_VOTRIENT_ONCOLOGY.